Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety. - Blum K; Lewandrowski APL; Sharafshah A; Pinhasov A; Mohankumar K; Gold MS; Fuehrlein B; Elman I; Dennen C; Thanos PK; Bowirrat A; Baron D; et al. (Current pharmaceutical biotechnology, 2026)